Sumatriptan oral tablet is a prescription drug that’s available as the brand-name drug Imitrex. It’s also available as a generic drug. Generic drugs usually cost less. In some cases, they may not be ...
PITTSBURGH, Aug. 10 /PRNewswire-FirstCall/ -- Mylan Inc. (NASDAQ: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received approval from the U ...
Mylan Laboratories Inc. said the U.S. Food and Drug Administration tentatively cleared its abbreviated new-drug application for sumatriptan succinate tablets in 25mg, 50mg and 100mg dosages.
NEW YORK (MarketWatch) -- Mylan Laboratories Inc., the Pittsburgh drugmaker, said the U.S. Food and Drug Administration tentatively cleared Mylan's abbreviated new-drug application for sumatriptan ...
What is sumatriptan used for? Sumatriptan is commonly used for the treatment of migraine with or without aura. An aura may occur before or during a migraine attack, and can include sensory problems ...
Sumatriptan oral tablets are a generic prescription medication. This medication is FDA-approved to treat migraine with or without aura in adults. Migraine is a neurological* condition that causes ...
Mylan (MYL) has been approved to make a generic version of migraine headache medicine Imitrex from GlaxoSmithkline and is set to ship the drug immediately. The tablets - whose scientific name is ...
Sumatriptan is a generic prescription drug used to treat migraine and cluster headaches in adults. It’s available in three forms: a tablet that you swallow nasal (nose) spray a liquid solution that’s ...
Sumatriptan is one of the most commonly prescribed medications to treat migraine attacks. As the pioneer in the triptan class ...
PITTSBURGH, Aug. 10 Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated ...
PITTSBURGH A major generic drug maker announced that it has received FDA approval for its version of a popular migraine drug. Mylan has received approval from the Food and Drug Administration for ...